Home › Calculator › VIAP Dividend Calculator 2026
VIAP Dividend DRIP Calculator 2026
400000.00% YieldHealthcareVIA Pharmaceuticals, Inc. · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When VIAP pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your VIAP snowball 📈
$10,000 in VIAP → $3.690270327864796e+47M in 10 years · $30,752,245,224,334,260,000,000,000,000,000,000,000,000,000,000,000,000.00/month
About VIA Pharmaceuticals, Inc. (VIAP) — Dividend Analysis 2026
VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily focused on discovering and advancing therapeutic compounds for cardiovascular and metabolic disorders. The firm is building a portfolio of small-molecule drug candidates designed to tackle the root causes of these health issues, such as vascular inflammation, elevated cholesterol and triglyceride levels, and insulin resistance or diabetes. Notable candidates in their development pipeline include: VIA-3196: A liver-specific thyroid hormone receptor (THR) beta agonist, poised for Phase 1 clinical studies. This drug aims to mitigate dyslipidemia, addressing high LDL cholesterol, elevated triglycerides, and Lp(a) levels. A Diacylglycerol Acyl Transferase 1 (DGAT1) inhibitor: Currently in preclinical development for treating type 2 diabetes, with promising potential for weight management and other lipid disorders. VIA-2291: A 5-Lipoxygenase inhibitor that has successfully completed its third Phase 2 clinical trial. Its purpose is to target atherosclerotic plaque, a significant contributor to heart attacks, strokes, and various other vascular diseases. VIA Pharmaceuticals has also forged two research, development, and commercialization agreements with Hoffman-LaRoche Inc. and Hoffman-LaRoche Ltd. These collaborations pertain to their THR beta agonist program and several compounds from their preclinical DGAT1 metabolic disorders initiative. Established in 2004, the company's headquarters are located in San Francisco, California.
Compare VIAP with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full VIAP DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open VIAP position with:
🌍 VIAP Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold VIAP.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 400000.00% | 399997.20% | $40,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 340000.00% | 339997.20% | $34,000,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 320000.00% | 319997.20% | $32,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 400000.00% | 399997.20% | $40,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 365000.00% | 364997.20% | $36,500,000 / yr |
| 🇨🇦 TFSA | 0% | 400000.00% | 399997.20% | $40,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 300000.00% | 299997.20% | $30,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 340000.00% | 339997.20% | $34,000,000 / yr |
| 🇦🇺 AU Taxable | 30% | 280000.00% | 279997.20% | $28,000,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 294500.00% | 294497.20% | $29,450,000 / yr |
| 🇫🇷 FR Taxable | 30% | 280000.00% | 279997.20% | $28,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 VIAP Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 VIAP Dividend Payment Schedule
VIAP pays quarterly — 4 times per year. Next ex-div: TBD.
📊 VIAP vs Healthcare Benchmarks
How VIAP compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for VIAP sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ VIAP Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2010-11-15 | 3,671,806 | $0.07 | $260.7K | ||
| Buy | 2010-11-15 | 60,495 | $0.07 | $4.3K | ||
| Other | 2010-04-01 | 40,000 | $2.38 | $95.2K | ||
| Other | 2010-04-01 | 9,300 | $3.48 | $32.4K | ||
| Other | 2010-04-01 | 6,691 | $0.14 | $937.00 | ||
| Buy | 2010-03-26 | 1,533,519 | $0.17 | $260.7K | ||
| Buy | 2010-03-26 | 25,265 | $0.17 | $4.3K | ||
| Buy | 2009-03-12 | 7,241,618 | $0.12 | $869.0K | ||
| Buy | 2009-03-12 | 119,308 | $0.12 | $14.3K | ||
| A-Award | 2008-12-17 | 125,000 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the VIAP dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
VIA Pharmaceuticals, Inc. (VIAP) is currently trading at $0.00, 98% below its 52-week high. The current dividend yield is 400000.00% based on an annual payout of $2.00 per share.
VIAP (VIA Pharmaceuticals, Inc.) — 400000.00% Dividend Yield Analysis
VIA Pharmaceuticals, Inc. (VIAP) is a healthcare stock currently trading at $0.00 with a dividend yield of 400000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (400000.00%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest VIAP News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.